The Directorate of Revenue Intelligence (DRI) has busted an illicit laboratory manufacturing alprazolam in Delhi's Ghazipur area, seizing 148 kg of alprazolam intermediate and arresting the person operating the facility, according to an agency statement issued through the Press Information Bureau on Wednesday. The premises were reportedly operating under the facade of a computer shop.

According to the DRI, officers searched the premises on 15 and 16 November 2026. The search revealed a fully functional clandestine laboratory equipped with reaction apparatus, a water chiller, a vacuum exhaust machine and other equipment used in the manufacturing process. The agency did not name the accused.

Besides the 148 kg of alprazolam intermediate in solid and liquid form, officers seized approximately 1,046 kg of raw materials and chemicals, along with 188 litres of additional chemicals and liquids. The equipment and materials were seized under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, and the case will be tested under its provisions.

Alprazolam is a benzodiazepine-class psychotropic substance, commonly sold under brand names such as Xanax and Alprax, and is a prescription medicine used primarily for anxiety and panic disorders. It is a notified psychotropic substance under the NDPS Act, and its unauthorised manufacture, possession, sale and distribution attract penal provisions.

The DRI said the operation was intelligence-led and described it as a significant crackdown on clandestine drug manufacture. The Delhi action follows its busting of a laboratory in Jalaun district of Uttar Pradesh on 29 October 2026, carried out with assistance from the Uttar Pradesh Anti-Terrorism Squad, in which about 1,100 kg of drugs and precursor chemicals were seized and two persons arrested. The DRI said the Delhi bust within weeks of the Jalaun operation underscores its intensified focus on dismantling illicit drug manufacturing facilities.